India, Sept. 18 -- New Delhi

The Delhi drugs control department on Wednesday directed manufacturers and marketers of pharmaceutical drugs and medical devices in Delhi to revise the maximum retail price (MRP) of their products, in line with the reduced Goods and Services Tax (GST) announced in the 56th GST Council meeting earlier this month.

The department has asked them to review their MRP by September 22.

"All the manufacturers and marketer of drugs, formulations & medical devices located in the jurisdiction of Delhi are required to revise the Maximum Retail Price (MRP) of drugs, formulations and medical devices as per revised GST rate w.e.f. 22.09.2025," a circular issued in this regard, a copy of which was accessed by HT, said.

In ...